Literature DB >> 14648103

Genetic polymorphisms and prostate cancer risk.

Andrea Gsur1, Elisabeth Feik, Stephan Madersbacher.   

Abstract

The identification of common genetic polymorphisms that influence susceptibility to PC would allow an early risk assessment with earlier and therefore potentially more effective intervention by chemopreventive means. In this review we focus on published case-control studies and meta-analyses of the following polymorphic genes that may play a role in etiology of the androgen receptor (AR), the prostate-specific antigen (PSA), 5alpha-reductase type II gene (SRD5A2), cytochrome P450c17alpha (CYP17), cytochrome P4503A4 (CYP3A4) and a putative hereditary PC susceptibility gene, ELAC2.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14648103     DOI： 10.1007/s00345-003-0378-4

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  101 in total

1.  More about: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

Authors:  T R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2000-01-05       Impact factor: 13.506

2.  Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.

Authors:  E M Lange; H Chen; K Brierley; E E Perrone; C H Bock; E Gillanders; M E Ray; K A Cooney
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.

Authors:  S W Huskey; D C Dean; R R Miller; G H Rasmusson; S H Chiu
Journal:  Drug Metab Dispos       Date:  1995-10       Impact factor: 3.922

4.  HPC2 variants and screen-detected prostate cancer.

Authors:  D Vesprini; R K Nam; J Trachtenberg; M A Jewett; S V Tavtigian; M Emami; M Ho; A Toi; S A Narod
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

5.  A polymorphism in the CYP17 gene and risk of prostate cancer.

Authors:  Janet L Stanford; Elizabeth A Noonan; Lori Iwasaki; Suzanne Kolb; Robert B Chadwick; Ziding Feng; Elaine A Ostrander
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-03       Impact factor: 4.254

6.  Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.

Authors:  Naomi E Allen; Juergen K V Reichardt; Hannah Nguyen; Timothy J Key
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

7.  Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme.

Authors:  D J Waxman; C Attisano; F P Guengerich; D P Lapenson
Journal:  Arch Biochem Biophys       Date:  1988-06       Impact factor: 4.013

8.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

Authors:  N L Chamberlain; E D Driver; R L Miesfeld
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

Review 9.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

10.  HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.

Authors:  J C Meitz; S M Edwards; D F Easton; A Murkin; A Ardern-Jones; R A Jackson; S Williams; D P Dearnaley; M R Stratton; R S Houlston; R A Eeles
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640
View more
  14 in total

1.  Predictive medicine in urology.

Authors:  Bernd J Schmitz-Dräger; Nuria Malats; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-18       Impact factor: 4.226

2.  Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.

Authors:  Akinobu Hamada; Romano Danesi; Douglas K Price; Tristan Sissung; Cindy Chau; David Venzon; Alex Sparreboom; William L Dahut; William D Figg
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

3.  Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis.

Authors:  Edmondo Falleti; Davide Bitetto; Carlo Fabris; Annarosa Cussigh; Elisabetta Fontanini; Ezio Fornasiere; Elisa Fumolo; Sara Bignulin; Sara Cmet; Rosalba Minisini; Mario Pirisi; Pierluigi Toniutto
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

4.  Increased risk of advanced prostate cancer associated with MnSOD Ala-9-Val gene polymorphism.

Authors:  Canan Kucukgergin; Oner Sanli; Tzevat Tefik; Makbule Aydın; Faruk Ozcan; Sule Seckin
Journal:  Mol Biol Rep       Date:  2011-05-08       Impact factor: 2.316

Review 5.  Genomics of prostate cancer: is there anything to "translate"?

Authors:  László Kopper; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

6.  The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Li-Xin Qiu; Ru-Tian Li; Jian-Bing Zhang; Wen-Zhao Zhong; Jian-Ling Bai; Bao-Rui Liu; Ming-Hua Zheng; Xiao-Ping Qian
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

7.  Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.

Authors:  Aruna V Sarma; Rodney L Dunn; Leslie A Lange; Anna Ray; Yunfei Wang; Ethan M Lange; Kathleen A Cooney
Journal:  Prostate       Date:  2008-02-15       Impact factor: 4.104

8.  TGFB1 gene polymorphism Leu10Pro (c.29T>C), prostate cancer incidence and quality of life in patients treated with brachytherapy.

Authors:  Andreas Meyer; Thilo Dörk; Natalia Bogdanova; Maria-Jantje Brinkhaus; Birgitt Wiese; Jörn Hagemann; Jürgen Serth; Michael Bremer; Rolf Baumann; Johann H Karstens; Stefan Machtens
Journal:  World J Urol       Date:  2008-11-28       Impact factor: 4.226

9.  Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.

Authors:  Akinobu Hamada; Tristan Sissung; Douglas K Price; Romano Danesi; Cindy H Chau; Nima Sharifi; David Venzon; Kenji Maeda; Keisuke Nagao; Alex Sparreboom; Hiroaki Mitsuya; William L Dahut; William D Figg
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

Review 10.  Genetic variation: effect on prostate cancer.

Authors:  Tristan M Sissung; Douglas K Price; Marzia Del Re; Ariel M Ley; Elisa Giovannetti; William D Figg; Romano Danesi
Journal:  Biochim Biophys Acta       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.